Clinical Trial Update: Efficacy and Safety of Eschscholtzia Californica in Treating Primary Insomnia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Eschscholzia californica for primary insomnia has been terminated, with efficacy and safety data reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Eschscholzia californica

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Sleep Initiation and Maintenance Disorders | Phase 3 | Status: TERMINATED